ArticleJournal of diabetes investigation2025
Red cell distribution width (RDW), RDW to albumin ratio (RAR), and long-term mortality in diabetic neuropathy: A NHANES analysis, 1999-2019.
Article in Journal of diabetes investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsWe aimed to explore associations between Red cell distribution width (RDW), RDW to albumin ratio (RAR), and long-term all-cause and cardiovascular disease (CVD) mortality in adults with diabetes and DN.
methodsThis study included adults aged ≥40 years with DN from the National Health and Nutrition Examination Survey from 1999 to 2004, followed through 2019. Cox proportional hazards models were used to assess associations between RDW, RAR, and all-cause and CVD mortality. Predictive accuracy was determined using area under the curve (AUC) by receiver operating characteristic analyses.
resultsData of a total of 624 participants with DN were analyzed. Each unit increase in RDW significantly increased all-cause mortality by 12% (adjusted hazard ratio (aHR) = 1.12, 95% CI: 1.05-1.20) and CVD mortality by 15% (aHR = 1.15, 95% CI: 1.02-1.31), while each unit increase in RAR increased all-cause mortality by 73% (aHR = 1.73) and CVD mortality by 93% (aHR = 1.93). In the highest versus lowest quartiles, RDW (aHR = 1.89) and RAR (aHR = 2.91) were associated with higher all-cause mortality risk, and even higher risk for CVD mortality (RDW: aHR = 2.86; RAR: aHR = 4.84). The AUC for 5-year predictions was RDW 0.825 and RAR 0.846 for all-cause mortality, and RDW 0.811 and RAR 0.814 for CVD mortality.
conclusionsRDW and RAR are strong predictors of long-term mortality in individuals with DN. RAR demonstrates stronger associations and higher predictive accuracy than RDW, particularly in predicting CVD mortality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.